ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 243 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $365,000 | +51.5% | 3,923 | -3.1% | 0.10% | +36.4% |
| Q3 2021 | $241,000 | -10.4% | 4,048 | +2.6% | 0.08% | -7.2% |
| Q2 2021 | $269,000 | +1.5% | 3,946 | +3.3% | 0.08% | -7.8% |
| Q1 2021 | $265,000 | -9.6% | 3,820 | 0.0% | 0.09% | -14.3% |
| Q4 2020 | $293,000 | +2.4% | 3,820 | 0.0% | 0.10% | -8.7% |
| Q3 2020 | $286,000 | +19.2% | 3,820 | 0.0% | 0.12% | +7.5% |
| Q2 2020 | $240,000 | +727.6% | 3,820 | +511.2% | 0.11% | +664.3% |
| Q3 2019 | $29,000 | -21.6% | 625 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $37,000 | – | 625 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |